• English
    X

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.

    Maryland Department of Health
    Prevention and Health Promotion Administration

    ​​

    Hepatitis C Fact Sheet

    PDF of this Fact Sheet

    Hepatitis C (HCV) is the virus that causes the liver disease Hepatitis C.
    HCV is found primarily in the blood. Hepatitis C can be both a short-term (acute) illness and an ongoing (chronic) infection that may gradually damage the liver. An estimated 75-85% of HCV-infected persons will develop chronic infection. In the US, chronic HCV is the most common reason for liver transplantation

     

    HCV is spread mainly by exposure to blood and blood products.

    HCV is spread when the blood of an infected person enters the body of a person who is not infected. Mainly this involves direct passage of blood through the skin, i.e. through sharing needles or “works” when injecting drugs. Much less often, sexual or mother-to-child transmission may occur. It is not spread by casual contact such as hugging, sharing food utensils, or sharing a bathroom. HCV is not spread by breastfeeding.


    Persons at highest risk for infection include people who:

    • Ever used illegal injection drugs (even if only once or just a few times, long ago)
    • Received blood transfusions, blood products, or donated organ or tissue before June 1992
    • Received clotting factors made before 1987


    Other risk groups include:

    •  Long-term dialysis patients
    • Healthcare workers who have a blood exposure (i.e. needlestick) to an infected person on the job
    • People born to a HCV-infected mother
    • Those who have had multiple sex partners, high-risk sexual behavior, and/or sexually transmitted disease
    • One notified that he/she received blood from a donor who later tested positive for HCV

     

    Symptoms to look for:

    • Fatigue
    • Yellow skin and eyes (jaundice)
    • Loss of appetite
    • Dark-colored urine
    • Nausea and vomiting
    • Joint Pain
    • Abdominal pain
    • Clay-colored stool

     

    Many persons have no symptoms of HCV infection. If a person does develop symptoms, , these symptoms may appear about 6 to 8 weeks after exposure, but this time period can vary among individuals. Some persons find out they are infected only after lab tests are done (for example, after giving blood).

     

    Diagnosis depends on a blood test.

    Testing for HCV is recommended if a person is in one or more of the increased risk categories listed above or has an undiagnosed liver problem. When you test positive for anti-HCV (screening test), it means you have been infected with HCV. It does not tell you whether you currently have HCV. Most people will still have the virus six months after infection (chronic), but 15-25% of persons have antibodies, but not the virus. In these people the immune system was able to get rid of the virus. Generally a confirmation test is indicated.

     

    Treatment is available for some people with HCV.
    There is treatment for HCV, and the medications used depends on the genetic makeup (or genotype) of the virus. The effectiveness of the treatment varies according to many factors, including the genotype, treatment regimen, and characteristics of the infected person.   Consultation with a healthcare provider is needed to discuss treatment options we well as other ways to  protect the liver, for example, by not drinking alcohol and avoiding certain medicines.

     

    Prevent hepatitis C by avoiding exposure and practicing good hygiene.
    Injecting drug users should not share needles or works with others. The use of latex condoms may decrease the risk of catching or passing HCV through sex.

     

    Persons with hepatitis C should get vaccination against hepatitis A and hepatitis B.

     

     

     

    ​